{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:42:37Z","timestamp":1789846957511,"version":"4.0.1"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,15]]},"DOI":"10.1097\/qai.0b013e318258b420","type":"journal-article","created":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T12:45:04Z","timestamp":1337172304000},"page":"455-461","source":"Crossref","is-referenced-by-count":11,"title":["Retrocyclin RC-101 Blocks HIV-1 Transmission Across Cervical Mucosa in an Organ Culture"],"prefix":"10.1097","volume":"60","author":[{"given":"Phalguni","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deena","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"Rohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Reinhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velpandi","family":"Ayyavoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xioli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy L.","family":"Patton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat","family":"Ramratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210131","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2307\/2991552","article-title":"Womens interest in vaginal microbicides.","volume":"31","author":"Darroch","year":"1999","journal-title":"Fam Plann Perspect"},{"key":"R2-2-20210131","first-page":"e351","article-title":"Which topical microbicides for blocking HIV-1 transmission will work in the real world PLoS Med.","volume":"3","author":"Klasse","year":"2006","journal-title":""},{"key":"R3-2-20210131","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":". Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"R4-2-20210131","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00126334-199005000-00005","article-title":". Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy.","volume":"3","author":"Baba","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-2-20210131","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/00002030-199810000-00004","article-title":". Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent.","volume":"12","author":"Balzarini","year":"1998","journal-title":"AIDS"},{"key":"R6-2-20210131","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1128\/JVI.71.4.3023-3030.1997","article-title":". Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase.","volume":"71","author":"Borkow","year":"1997","journal-title":"J Virol"},{"key":"R7-2-20210131","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0166-3542(87)90018-0","article-title":". Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro.","volume":"7","author":"Ito","year":"1987","journal-title":"Antiviral Res"},{"key":"R8-2-20210131","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1128\/AAC.42.6.1484","article-title":"Antiviral activities of 9-R-2-phosphonomethoxypropyl adenine (PMPA) and bis(isopropyloxymethylcarbonyl)PMPA against various drug-resistant human immunodeficiency virus strains.","volume":"42","author":"Srinivas","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-2-20210131","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1128\/AAC.01358-06","article-title":". Effect of topical microbicides on infectious human immunodeficiency virus type 1 binding to epithelial cells.","volume":"51","author":"Roth","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-2-20210131","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1086\/462424","article-title":". A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection.","volume":"192","author":"Abner","year":"2005","journal-title":"J Infect Dis"},{"key":"R11-2-20210131","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/74743","article-title":". Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract.","volume":"6","author":"Collins","year":"2000","journal-title":"Nat Med"},{"key":"R12-2-20210131","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/vr.155.7.208","article-title":". Hydrocephalus in a newborn bottlenosed dolphin (Tursiops truncatus).","volume":"155","author":"Corpa","year":"2004","journal-title":"Vet Rec"},{"key":"R13-2-20210131","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1089\/aid.2006.22.788","article-title":". Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load.","volume":"22","author":"Cummins","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R14-2-20210131","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1128\/AAC.01129-06","article-title":". Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture.","volume":"51","author":"Cummins","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R15-2-20210131","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/01.aids.0000232230.96134.80","article-title":". Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides.","volume":"20","author":"Fletcher","year":"2006","journal-title":"AIDS"},{"key":"R16-2-20210131","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1128\/JVI.74.12.5577-5586.2000","article-title":". Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides.","volume":"74","author":"Greenhead","year":"2000","journal-title":"J Virol"},{"key":"R17-2-20210131","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0923-2516(07)80017-3","article-title":". In vitro HIV1 infection of human cervical tissue.","volume":"145","author":"Palacio","year":"1994","journal-title":"Res Virol"},{"key":"R18-2-20210131","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00002030-200303280-00002","article-title":". Blocking of cell-free and cell-associated HIV-1 transmission through human cervix organ culture with UC781.","volume":"17","author":"Zussman","year":"2003","journal-title":"AIDS"},{"key":"R19-2-20210131","doi-asserted-by":"crossref","first-page":"9868","DOI":"10.1128\/JVI.76.19.9868-9876.2002","article-title":". Memory CD4() T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system.","volume":"76","author":"Gupta","year":"2002","journal-title":"J Virol"},{"key":"R20-2-20210131","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/aid.2006.22.419","article-title":". Use of frozen-thawed cervical tissues in the organ culture system to measure anti-HIV activities of candidate microbicides.","volume":"22","author":"Gupta","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R21-2-20210131","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1258\/0956462971919994","article-title":". Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia.","volume":"8","author":"Hira","year":"1997","journal-title":"Int J STD AIDS"},{"key":"R22-2-20210131","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJM199808203390803","article-title":". A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.","volume":"339","author":"Roddy","year":"1998","journal-title":"N Engl J Med"},{"key":"R23-2-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00126334-200101010-00003","article-title":". Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites.","volume":"26","author":"van De Wijgert","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R24-2-20210131","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1371\/journal.pmed.0050028","article-title":". Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.","volume":"5","author":"Garcia-Lerma","year":"2008","journal-title":"PLoS Med"},{"key":"R25-2-20210131","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/QAI.0b013e31802bb35f","article-title":". Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers.","volume":"44","author":"Jespers","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R26-2-20210131","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/jwh.2006.0325","article-title":". Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study.","volume":"17","author":"Rosen","year":"2008","journal-title":"J Womens Health (Larchmt)"},{"key":"R27-2-20210131","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2006.06.026","article-title":". Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.","volume":"325","author":"Woolfson","year":"2006","journal-title":"Int J Pharm"},{"key":"R28-2-20210131","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(09)61615-9","article-title":"Quarraisha Abdool Karim: investigating HIVAIDS in South Africa. Interview by Priva Shetty.","volume":"374","author":"Karim","year":"2009","journal-title":"Lancet"},{"key":"R29-2-20210131","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20031266","article-title":". Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.","volume":"198","author":"Veazey","year":"2003","journal-title":"J Exp Med"},{"key":"R30-2-20210131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature04055","article-title":". Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.","volume":"438","author":"Veazey","year":"2005","journal-title":"Nature"},{"key":"R31-2-20210131","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.virol.2007.03.001","article-title":". Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.","volume":"364","author":"Ketas","year":"2007","journal-title":"Virology"},{"key":"R32-2-20210131","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1073\/pnas.052706399","article-title":". Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.","volume":"99","author":"Cole","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-2-20210131","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1089\/088922203322493049","article-title":". The theta-defensin, retrocyclin, inhibits HIV-1 entry.","volume":"19","author":"Munk","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R34-2-20210131","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/aid.2004.20.1157","article-title":". RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates.","volume":"20","author":"Owen","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R35-2-20210131","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1128\/AAC.01190-10","article-title":". Formulation development of retrocyclin 1 analog RC-101 as an anti-HIV vaginal microbicide product.","volume":"55","author":"Sassi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R36-2-20210131","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1128\/CDLI.4.1.4-10.1997","article-title":"A semiquantitative assay for CD8 T-cell-mediated suppression of human immunodeficiency virus type 1 infection.","volume":"4","author":"Chen","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"R37-2-20210131","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.1128\/JVI.01979-07","article-title":". Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells.","volume":"82","author":"Majumder","year":"2008","journal-title":"J Virol"},{"key":"R38-2-20210131","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1128\/CVI.00104-09","article-title":". Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells.","volume":"16","author":"Huang","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"R39-2-20210131","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.4049\/jimmunol.180.8.5530","article-title":". Chemokine and cytokine mediated loss of regulatory T cells in lymph nodes during pathogenic simian immunodeficiency virus infection.","volume":"180","author":"Qin","year":"2008","journal-title":"J Immunol"},{"key":"R40-2-20210131","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00007435-199107000-00010","article-title":"The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa.","volume":"18","author":"Niruthisard","year":"1991","journal-title":"Sex Transm Dis"},{"key":"R41-2-20210131","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00007435-200210000-00004","article-title":". Rectal applications of nonoxynol-9 cause tissue disruption in a monkey model.","volume":"29","author":"Patton","year":"2002","journal-title":"Sex Transm Dis"},{"key":"R42-2-20210131","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/095646249300400308","article-title":". A dosing study of nonoxynol-9 and genital irritation.","volume":"4","author":"Roddy","year":"1993","journal-title":"Int J STD AIDS"},{"key":"R43-2-20210131","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1371\/journal.pbio.1000095","article-title":". Reawakening retrocyclins: ancestral human defensins active against HIV-1.","volume":"7","author":"Venkataraman","year":"2009","journal-title":"PLoS Biol"},{"key":"R44-2-20210131","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1056\/NEJMoa0707957","article-title":". Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.","volume":"359","author":"Van Damme","year":"2008","journal-title":"N Engl J Med"},{"key":"R45-2-20210131","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/AAC.00984-06","article-title":". Preclinical safety assessments of UC781 anti-human immunodeficiency virus topical microbicide formulations.","volume":"51","author":"Patton","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R46-2-20210131","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM199302043280508","article-title":"New concepts in the immunopathogenesis of human immunodeficiency virus infection.","volume":"328","author":"Pantaleo","year":"1993","journal-title":"N Engl J Med"},{"key":"R47-2-20210131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/aid.1992.8.191","article-title":"The effect of cytokines and pharmacologic agents on chronic HIV infection.","volume":"8","author":"Poli","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R48-2-20210131","doi-asserted-by":"crossref","first-page":"e15111","DOI":"10.1371\/journal.pone.0015111","article-title":". The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaques.","volume":"5","author":"Cole","year":"2010","journal-title":"PLoS One"},{"key":"R49-2-20210131","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.4049\/jimmunol.176.11.6900","article-title":". HIV-1 adapts to a retrocyclin with cationic amino acid substitutions that reduce fusion efficiency of gp41.","volume":"176","author":"Cole","year":"2006","journal-title":"J Immunol"},{"key":"R50-2-20210131","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.peptides.2003.07.023","article-title":"Evolution of primate theta-defensins: a serpentine path to a sweet tooth.","volume":"24","author":"Nguyen","year":"2003","journal-title":"Peptides"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-201208150-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:53:47Z","timestamp":1618037627000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201208150-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,15]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318258b420","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8,15]]}}}